Dolby Laboratories (NYSE: DLB) reported Q4 EPS of $0.54, $0.09 better than the analyst estimate of $0.45. Revenue for the quarter came in at $278.2 million versus the consensus estimate of $306.26 million.

GUIDANCE:

Dolby Laboratories sees Q1 2023 EPS of $0.76-$0.91, versus the consensus of $1.10. Dolby Laboratories sees Q1 2023 revenue of $300-330 million, versus the consensus of $364 million.

Dolby is providing the following high-level estimates for the full year of fiscal 2023:

• Total revenue is expected to grow low single digits year-over-year.
• GAAP operating expenses are expected to decline roughly 2% year-over-year. Non-GAAP operating expenses are expected to grow roughly 2% year-over-year.
• We expect operating margins on a GAAP basis to be roughly 19% and on a non-GAAP basis to be roughly 30%.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.